AI evidence summary · MVP
Ginger for Migraine
AI preliminary evidence assessment
CC 級|AI 整體初步評級
This preliminary assessment is currently available in Traditional Chinese.
Exact question對有偏頭痛的成人,口服薑製劑相較匹配安慰劑或相同共照,是否改善急性發作疼痛或預防發作,並有哪些不良反應?
已驗證評讀顯示研究結果方向不一致。主要限制包括:原31筆中2納入、10背景、17排除、2未解;本次14份均審查,未解書目維持背景。僅代表指定PubMed檢索,無系統搜尋完整性主張;主要臨床來源僅摘要,未核全文;資助、流失及不良事件數未知。未報安全結果不代表無事件。
Additional assessment reasons await presentation; see the research results below.
Limitations affecting this assessment
- S/A/B/C/D/U 為初步編輯分類;本次 C 表示療效訊號有限且不確定,不是正式 GRADE 評級。confidence 表示對本次判讀的把握度,不是療效機率。
- 本次僅評估提供的14份凍結來源。31筆中性 PubMed 紀錄已篩查,但2筆仍未解;不能宣稱系統性搜尋或納入試驗覆蓋完整。
- 主要臨床來源為摘要,未核實全文;未報告的劑量、資助、利益衝突、不良事件數、依從性、失訪及停藥原因均維持未知,限制偏倚與安全性評估。
- 2026年回顧的納入研究表與全文不可得,所指出版社資料 DOI XN9FM1 回傳404;無法逐一核對8項試驗、全部研究家族、世代重疊及其偏倚。
- 直接證據主要涉及成人陣發性偏頭痛;不同配方、給藥途徑、共照及急性或預防用途不能合併外推至所有口服薑製劑或慢性偏頭痛。
- 此背景讀者事實的必要欄位缺少足夠來源支持,因此未列為讀者研究結果,也未納入評級;同來源其他可驗證資訊仍分開保留。
- 此背景讀者事實的必要欄位缺少足夠來源支持,因此未列為讀者研究結果,也未納入評級;同來源其他可驗證資訊仍分開保留。
- 2026年系統性回顧(PMID42601183)另報告預防性加用薑與相同活性藥物共照比較:2項研究、183人,3個月頭痛疼痛嚴重度平均差為−3.18(95%信賴區間−3.94至−2.42),屬正向但低確定性證據;整體各結局的證據確定性為低至極低。這與薑單方的安慰劑預防試驗不同,不能用加藥結果取代單方未優於安慰劑的結果,也不能據此證明減少發作頻率。回顧納入表及這兩項加藥研究的原文身份未核,不能宣稱已逐一涵蓋全部8項試驗。
- 本次系統性回顧未被納入該計分欄位,依原規則採0.5中性政策值。這不是研究支持票,也不表示文獻中沒有系統性回顧。
- 原31筆中2納入、10背景、17排除、2未解;本次14份均審查,未解書目維持背景。僅代表指定PubMed檢索,無系統搜尋完整性主張。
- 主要臨床來源僅摘要,未核全文;資助、流失及不良事件數未知。未報安全結果不代表無事件。
- 最新回顧納入表及全文不可用,資料DOI XN9FM1回傳404;不能宣稱已覆蓋全部八試驗。其預防加藥正向結果與單用薑的安慰劑試驗範圍不同。
- 急性共照、單用預防、活性藥及舌下複方各自解讀;背景報告不增加獨立療效證據。
- 兩項直接試驗依摘要明載註冊號及官方不同研究計畫、招募期間確認為不同試驗單位;急性與預防效果分開,不表示所有參與者絕無重疊,不把複方或活性對照報告加為本問題的獨立療效票。最新回顧提及的其他預防加成試驗原文身份未核,不能宣稱涵蓋全部八項試驗。
Research results
Findings are currently provided in Traditional Chinese; source excerpts retain their original language.
Main result 1
1、1.5、2小時臨床反應較佳,p依序0.04、0.01、0.04;所有評估時點疼痛下降、功能改善。無可抽取絕對效應或反應人數。
Applicability assessment: 納入急診就醫的成人陣發性偏頭痛患者,兩組均接受相同的酮洛芬治療。
- Population
- 急診就醫的成人陣發性偏頭痛患者
- Intervention
- 薑萃取物加靜脈注射酮洛芬
- Comparator
- 纖維素安慰劑加靜脈注射酮洛芬
- Outcome
- 急性發作疼痛與功能狀態
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- 口服薑萃取物400 mg,5%活性成分,急性發作時加用
Source excerpt: ginger treatment promoted reduction in pain and improvement on functional status at all times assessed.View source
Main result 2
三個月發作數減少至少50%的反應比例無組間差異;嚴重疼痛天數、急性止痛藥使用與發作持續時間兩組均下降,但薑無顯著優勢。
Applicability assessment: 納入未使用預防藥物的成人陣發性偏頭痛患者,以安慰劑作比較。
- Population
- 18至60歲、未服用預防藥物的陣發性偏頭痛患者
- Intervention
- 每日三次、每次200毫克的乾薑萃取物膠囊
- Comparator
- 纖維素安慰劑
- Outcome
- 偏頭痛發作預防
- Follow-up
- 三個月
- Formulation
- Not established
- Dose
- 口服乾薑萃取物200 mg每日三次,5%活性成分,共三個月
Source excerpt: Ginger provides no greater benefit in the prophylactic treatment of migraine when compared to placebo.View source
Additional finding 3
一個月期間治療偏頭痛發作兩小時時,複方組與安慰劑組無痛受試者比例分別為32%與16%。
Applicability assessment: 納入偏頭痛發作並設匹配安慰劑組;研究製劑為舌下小白菊與薑複方。
- Population
- 符合國際頭痛學會偏頭痛診斷標準的受試者
- Intervention
- 舌下小白菊與薑複方
- Comparator
- 匹配安慰劑
- Outcome
- 治療後兩小時無痛
- Follow-up
- 一個月期間治療偏頭痛發作
- Formulation
- Not established
- Dose
- Not established
Source excerpt: At 2 hours, 32% of subjects receiving active medication and 16% of subjects receiving placebo were pain-freeView source
Additional finding 4
摘要稱使用任一藥物後兩小時平均頭痛嚴重度均下降,並稱兩者療效相近。
Applicability assessment: 研究急性無先兆偏頭痛發作時使用薑粉。
- Population
- 急性無先兆偏頭痛患者
- Intervention
- 薑粉
- Comparator
- 舒馬曲坦
- Outcome
- 用藥後兩小時頭痛嚴重度
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- Not established
Source excerpt: Two hours after using either drug, mean headaches severity decreased significantly. Efficacy of ginger powder and sumatriptan was similar.View source
Additional finding 5
統合分析納入三項隨機對照試驗。
Applicability assessment: 彙整薑與安慰劑治療偏頭痛的隨機試驗。
- Population
- 偏頭痛患者
- Intervention
- 薑治療
- Comparator
- 安慰劑
- Outcome
- 偏頭痛治療結果
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- Not established
Source excerpt: Three RCTs are included in the meta-analysis.View source
Additional finding 6
文章概述一項預防試驗與一項急性治療統合分析。
Applicability assessment: 文章討論薑用於偏頭痛,並概述預防試驗及統合分析。
- Population
- 偏頭痛患者
- Intervention
- 薑
- Comparator
- 安慰劑
- Outcome
- 偏頭痛發作預防及治療後兩小時無痛
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- Not established
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceAdditional finding 7
回顧納入八項隨機對照試驗,涉及594名患者。
Applicability assessment: 系統性回顧涵蓋薑單用或加用治療偏頭痛的隨機試驗。
- Population
- 偏頭痛患者
- Intervention
- 薑單用或加用治療
- Comparator
- 安慰劑或常規活性治療
- Outcome
- 急性頭痛結果及偏頭痛發作頻率與持續時間
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- Not established
Source excerpt: Eight RCTs involving 594 patients were included.View source
Sources consulted
- A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine. Context source; not counted as an included human-result report Abstract only · 2026-10-05T09:44:26.819407Z
- Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Context source; not counted as an included human-result report Abstract only · 2026-10-05T09:44:26.819407Z
- Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment. Abstract only · 2026-10-05T09:44:26.819407Z
- Double-blind placebo-controlled randomized clinical trial of ginger (Zingiber officinale Rosc.) in the prophylactic treatment of migraine. Abstract only · 2026-10-05T09:44:26.819407Z
- The efficacy of ginger for the treatment of migraine: A meta-analysis of randomized controlled studies. Context source; not counted as an included human-result report Abstract only · 2026-10-05T09:44:26.819407Z
- Ginger for Migraine. Context source; not counted as an included human-result report Abstract only · 2026-10-05T09:44:26.819407Z
- Ginger for the treatment and prevention of migraine headaches: a systematic review and meta-analysis of randomised controlled trials. Context source; not counted as an included human-result report Abstract only · 2026-10-05T09:44:26.819407Z
Reading and assessment notes
This is an AI preliminary assessment, not expert review or formal GRADE. Read the method and common limitations.
Absence of reported harms does not establish safety. This summary does not provide individual treatment or dosing advice.
Data and assessment record
Search coverage for this case
對有偏頭痛的成人,口服薑製劑相較匹配安慰劑或相同共照,是否改善急性發作疼痛或預防發作,並有哪些不良反應?
Searched:2026-10-05T09:44:26.819407Z · Databases:PubMed
31 records identified; 31 screened; 2 reports from 2 unique study populations included.
Some included reports were assessed without full text.
- 部分候選文獻未取得全文,完整偏倚風險與次要結果評讀受限。
- 系統檢索限於 PubMed;未涵蓋所有資料庫與完整引文追查。
Processing record
Evidence summary available
Sources through:2026-10-05 · Generated:2026-10-05T10:27:37.054937+00:00
Retrieved 31 records · Screened 31 · Included 2 reports · Omitted 29
Run:rating-candidate-final-v2
codex_cli / gpt-6.1-sol / problem-search-source-bound-l2+l11-v1
{
"included": 2,
"limits_hit": [
"fulltext_unavailable",
"limited_citation_tracing"
],
"omitted": 29,
"retrieved": 31,
"screened": 31
} sha256:b36d7a6a6ad3c3e188619cdeabfa37f531acbec13338dfbead822e617a5cf158